Altogether, adult studies have identified a slight improvement in glycemic control, weight, and bolus insulin dose among patients with type 1 diabetes on combined therapy of insulin and GLP-1 agonists, but not DPP-4 inhibitors. Here, INS is linked to type 1 diabetes mellitus.